Every investor is looking for opportunities, but finding promising stocks and deciding when to buy is rarely a simple task. Successful investing often depends on separating temporary market moves from ...

Modern biopharma firms are adapting their R&D investment strategies in response to challenges such as the impending $300 ...

Discover the 25 countries leading the world in technology right now. Explore top nations driving innovation, R&D, and digital ...

Deadline to register is July 21. For more details, visit The IC3 Movement’s 10th Annual Conference and Expo 2026 will be on ...

Permeasis Therapeutics (“Permeasis”), a biotechnology company developing intracellular biologics enabled by its proprietary Membrane Translocation Domain (MTD) platform announced the publication of ...

While many of life's mysteries remain unsolved, every biologist can describe the basic processes performed by a living organism, including energy use, reproduction, growth and development. While these ...

SkinTE® would be the first new biologic commercially available in the U.S. for the treatment of a common chronic wound indication in nearly 30 years, if approved. SkinTE® is a first-in-class ...

In recent years, the concept of postbiotics has gained substantial as an increase of microbiome-based therapies. In contrast to probiotics, postbiotics are ...

HKEX Tech 100 Index ETF (3456) tracking the HKEX Tech 100 Index, E Fund is deeply honored. This is not only an important step ...

Highly sensitive next-generation sequencing-based MRD testing will identify eligible patients with T-cell malignancies ...

What do Botox, rat poison, weight-loss drugs and a fictional murder investigation have in common? At the University of Nevada ...

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food ...